IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma

Growth Hormone and IGF Research

Volumn 19, Issue 6, 2009, Pages 507-512

  Brandt, Katrin ^a   Wang, Jing ^a   Lundell, Kerstin ^a   Ståhlberg, Marie ^b   Horn, Henrik von ^a   Ehrenborg, Ewa ^b   Hall, Kerstin ^a   Jörnvall, Hans ^b   Lewitt, Moira ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Azurocidin heparin binding protein CAP37; IGF binding protein 1; IGFBP protease; Insulin like growth factor; Multiple myeloma

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; MASS SPECTROMETRY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; BIOTINYLATION; BLOOD PROTEINS; CARRIER PROTEINS; CHROMATOGRAPHY; DERMATITIS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MULTIPLE MYELOMA; PROTEIN ISOFORMS; RADIOIMMUNOASSAY; RECOMBINANT PROTEINS; SEPHAROSE;

EID: 70349559799     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.05.002     Document Type: Article

References (35)

1. Bach L.A., Headey S.J., and Norton R.S. IGF-binding proteins - the pieces are falling into place. Trends Endocrinol. Metab. 16 (2005) 228-234
2. Rajaram S., Baylink D.J., and Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 18 (1997) 801-831
3. Lewitt M.S. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diab. Res. Clin. Pract. 23 (1994) 3-15
4. Lee P.D.K., Giudice L.C., Conover C.A., and Powell D.R. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc. Soc. Exp. Biol. Med. 216 (1997) 319-357
5. Gibson J.M., Aplin J.D., White A., and Westwood M. Regulation of IGF bioavailability in pregnancy. Mol. Hum. Reprod. 7 (2001) 79-87
6. Leu J.I., Crissey M.A., and Taub R. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J. Clin. Invest. 111 (2003) 129-139
7. Perks C.M., Newcombe P.V., Norman M.R., and Holly J.M.P. Effect of insulin-like growth factor binding protein-1 on integrin signaling and the induction of apoptosis in human breast cancer cells. J. Mol. Endocrinol. 22 (1999) 141-150
8. Coverley J.A., Martin J.L., and Baxter R.C. The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 141 (2000) 564-570
9. Neumann G.M., Marinaro J.A., and Bach L.A. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6. Biochemistry 37 (1998) 6572-6585
10. Wang J., Shafqat J., Hall K., Ståhlberg M., Wivall-Helleryd I.-L., Bouzakri K., Zierath J.R., Jörnvall H., and Lewitt M.S. Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity. Cell. Mol. Life Sci. 63 (2006) 2405-2414
11. Campanelli D., Detmers P.A., Nathan C.F., and Gabay J.E. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 85 (1990) 904-915
12. Pereira H.A., Shafer W.M., Pohl J., Martin L.E., and Spitznagel J.K. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest. 85 (1990) 1468-1476
13. Wilde C.G., Snable J.L., Griffith J.E., and Scott R.W. Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase. J. Biol. Chem. 265 (1990) 2038-2041
14. Rechler M.M., and Clemmons D.R. Regulatory actions of insulin-like growth factor-binding proteins. Trends Endocrinol. Metab. 9 (1998) 176-183
15. Lalou C., Lassarre C., and Binoux M. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137 (1996) 3206-3212
16. 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. (USA) 90 (1993) 10553-10557
17. Sala A., Capaldi S., Campagnoli M., Faggion B., Labo S., Perduca M., Romano A., Carrizo M.E., Valli M., Visai L., Minchiotti L., Galliano M., and Monaco H.L. Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid. J. Biol. Chem. 280 (2005) 29812-29819
18. Salahifar H., Firth S.M., Baxter R.C., and Martin J.L. Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells. Growth Horm. IGF Res. 10 (2000) 367-377
19. Roblick U.J., Hirschberg D., Habermann J.K., Palmberg C., Becker S., Kruger S., Gustafsson M., Bruch H.P., Franzen B., Ried T., Bergmann T., Auer G., and Jörnvall H. Sequential proteome alterations during genesis and progression of colon cancer. Cell. Mol. Life Sci. 61 (2004) 1246-1255
20. Póvoa G., Roovete A., and Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol. 107 (1984) 563-570
21. Brinkman A., Groffen C.A.H., Kortleve D.J., and Drop S.L.S. Organization of the gene encoding the insulin-like growth factor binding protein IBP-1. Biochem. Biophys. Res. Commun. 157 (1988) 898-907
22. 2-Macroglobulin: a new component in the IGF/IGFBP-1 axis. J. Biol. Chem. 23 (2001) 41668-41674
23. Sakai K., Busby Jr. W.H., Clarke J.B., and Clemmons D.R. Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis. J. Biol. Chem. 276 (2001) 8740-8745
24. Brinkman A., Kortleve D.J., Zwarthoff E.C., and Drop S.L.S. Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity. Mol. Endocrinol. 5 (1991) 987-994
25. Kiepe D., Andress D.L., Mohan S., Standker L., Ulinski T., Himmele R., Mehls O., and Tonshoff B. Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. J. Am. Soc. Nephrol. 12 (2001) 2400-2410
26. Schebek-Furstenberg V., Standker L., Oppermann M., Muller-Wiefel D.E., Hahn W., Blum W.F., Braulke T., and Kubler B. IGF-binding protein-3 fragments in plasma of a child with acute renal failure. Pediatr. Nephrol. 19 (2004) 1418-1425
27. Maile L.A., Whellams E.J., and Holly J.M.P. Endogenous IGFBP-3 is protected from inducible IGFBP-3 protease activity in normal adult serum. Growth Horm. IGF Res. 10 (2000) 71-77
28. Koistinen H., Paju A., Koistinen R., Finne P., Lovgren J., Wu P., Seppala M., and Stenman U.H. Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Prostate 50 (2002) 112-118
29. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes Jr. D.R., Virmani R., Oxvig C., and Schwartz R.S. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. New Engl. J. Med. 345 (2001) 1022-1029
30. Watorek W. Azurocidin - inactive serine proteinase homolog acting as a multifunctional inflammatory mediator. Acta Biochim. Pol. 50 (2003) 743-752
31. Lee T.D., Gonzalez M.L., Kumar P., Chary-Reddy S., Grammas P., and Pereira H.A. CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am. J. Pathol. 160 (2002) 841-848
32. Pereira H.A., Kumar P., and Grammas P. Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol. Aging 17 (1996) 753-759
33. Jelinek D.F., Witzig T.E., and Arendt B.K. A role for insulin-like growth factor in the regulation of Il-6-responsive human myeloma cell line growth. J. Immunol. 159 (1997) 487-496
34. Burgess W., Jesse K., Tang Q., Broussard S.R., Dantzer R., and Kelley K.W. Insulin-like growth factor-I and the cytokines IL-3 and IL-4 promote survival of progenitor myeloid cells by different mechanisms. J. Neuroimmunol. 135 (2003) 82-90
35. Qiang Y.W., Yao L., Tosato G., and Rudikoff S. Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood 103 (2003) 301-308